IFCC Survey on Molecular Diagnostics and Circulating Biomarkers
LabMed is inviting members to take part in the survey conducted by IFCC committee on Molecular Diagnostics (C-MDO) to understand how molecular diagnostics based on circulating biomarkers, including cell-free nucleic acids, circulating tumour cells and extracellular vesicles, are currently being implemented in diagnostic laboratories worldwide.
The survey aims to identify current practices, unmet needs and areas where greater harmonisation and standardisation may be needed. The findings will contribute to the development of future IFCC C-MDO recommendations and educational activities.